This new publication is an analysis of cancer registration data and mortality data over a five-year period. Its purpose is to give a measure of the comparative survival of cancer patients for 20 sites of cancer.
The cancer registration data used is from the years 1994 to 2003. This period follows the introduction of the Cancer Registry Act 1993, which resulted in more complete reporting of the incidence of cancer in New Zealand.
The sites for which survival data was calculated are:
- head, neck and larynx
- oesophagus
- stomach
- colorectum and anus
- liver and intrahepatic bile ducts
- pancreastrachea, bronchus and lung
- malignant melanoma of the skin
- female breast
- cervix uteri
- corpus uteri
- ovary
- prostate
- testis
- bladder
- kidney, ureter and urethra
- brain
- thyroid gland
- non-Hodgkin’s lymphoma
- leukaemia (all forms).